Related references
Note: Only part of the references are listed.The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
Holis Abdul Holik et al.
MOLECULES (2022)
3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals
Stephen Ahenkorah et al.
THERANOSTICS (2022)
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu
Lachlan E. McInnes et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Evaluation of 177Lu and 47Sc Picaga-Linked, Prostate-Specific Membrane Antigen-Targeting Constructs for Their Radiotherapeutic Efficacy and Dosimetry
Brett A. Vaughn et al.
MOLECULAR PHARMACEUTICS (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability
Irwin Cassells et al.
FRONTIERS IN MEDICINE (2021)
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer
Yana Dekempeneer et al.
MOLECULAR PHARMACEUTICS (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
New Bifunctional Chelator 3p-C-NEPA for Potential Applications in Lu(III) and Y(III) Radionuclide Therapy and Imaging
Xiang Sun et al.
ACS OMEGA (2020)
Automated GMP compliant production of [18F]AlF-NOTA-octreotide
Terence Tshibangu et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2020)
A novel clickable MSAP agent for dual fluorescence/nuclear labeling of biovectors
Kuo-Ting Chen et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2020)
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
Petra Kolenc Peitl et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Maintaining radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 for PRRT by reducing radiolysis
Rory M. S. de Zanger et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2019)
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Thomas I. Kostelnik et al.
CHEMICAL REVIEWS (2019)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+., and 225AC3+
James M. Kelly et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models
Vincent Bouvet et al.
EJNMMI RESEARCH (2016)
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benesova et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Retention of [18F]fluoride on reversed phase HPLC columns
Dieter Ory et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using 90Y or 177Lu
Chi Soo Kang et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Alternative Method to Determine Specific Activity of 177Lu by HPLC
Wouter A. P. Breeman et al.
CURRENT RADIOPHARMACEUTICALS (2015)
Matching chelators to radiometals for radiopharmaceuticals
Eric W. Price et al.
CHEMICAL SOCIETY REVIEWS (2014)
Effectiveness of Quenchers to Reduce Radiolysis of 111In- or 177Lu-Labelled Methionine-Containing Regulatory Peptides. Maintaining Radiochemical Purity as Measured by HPLC
Erik de Blois et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: Radiolabeling, serum stability, and biodistribution and tumor uptake studies
Chi Soo Kang et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Synthesis and Preclinical Evaluation of Bifunctional Ligands for Improved Chelation Chemistry of 90Y and 177Lu for Targeted Radioimmunotherapy
Chi Soo Kang et al.
BIOCONJUGATE CHEMISTRY (2012)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
C. Barinka et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection
Rafael Fridman et al.
NATURE PROTOCOLS (2012)
Efficient Bifunctional Decadentate Ligand 3p-C-DEPA for Targeted α-Radioimmunotherapy Applications
Hyun A. Song et al.
BIOCONJUGATE CHEMISTRY (2011)
Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates
Mamta Dadwal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
A Novel Method of 18F Radiolabeling for PET
William J. McBride et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Efficient synthesis and evaluation of bimodal ligand NETA
Hyun-Soon Chong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents
Hyun-Soon Chon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
In vitro and in vivo evaluation of novel ligands for radioimmunotherapy
Hyun-Soon Chong et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)